retatrutide ly3437943 triple agonist glp-1 gip glucagon Biggest obesity news π¨ TRIUMPH-1 results are here: Retatrutide's phase 3 trial showed up to 28% average weight loss over 80 weeks β with nearly half of patients losing over 30% of Retatrutide vs Tirzepatide: Triple vs
Pay in 4 interest-free payments of $5.91 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 22 - Aug 27



























